Sep 06, 2024
227:213
For every 213 shares held, investors received 227. The price per share adjusted from $0.05 to $0.04.
The split itself did not change the total investment value.
Lumos Diagnostics Holdings Ltd. (ASX:LDX) operates in the Medical specialties industry.
Lumos Diagnostics Holdings Ltd. company overviewLumos Diagnostics Holdings Ltd.'s most recent stock split was on September 6, 2024. It was a 227-for-213 forward split, so shareholders received 227 shares for every 213 they held.
Lumos Diagnostics Holdings Ltd. (ASX:LDX) has split its stock 2 times: a 51-for-47 split on June 8, 2022 and a 227-for-213 split on September 6, 2024.
Lumos Diagnostics Holdings Ltd. has split its stock 2 times. This history records 2 forward splits between June 8, 2022 and September 6, 2024.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Lumos Diagnostics Holdings Ltd.'s 227-for-213 split on September 6, 2024, every 213 shares became 227 shares.
Lumos Diagnostics Holdings Ltd. has not announced a new split in our records. Its most recent split was on September 6, 2024, 2 years ago. Companies announce splits in advance, and any new ASX:LDX split will appear on this page.
Already premium?